Cartesian Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $452 | $298 | $1,100 | $-759 |
Gross Profit | -12,345 | 298 | 1,100 | -759 |
EBITDA | -35,296 | 16,475 | -20,733 | -9,480 |
EBIT | -35,902 | 15,886 | -21,889 | -9,966 |
Net Income | -35,902 | 15,886 | -17,710 | -10,253 |
Net Change In Cash | 452 | 298 | 1,100 | -759 |
Free Cash Flow | -16,892 | -20,116 | -24,183 | -7,707 |
Cash | 143,384 | 160,324 | 180,434 | 212,610 |
Basic Shares | 26,002 | 26,447 | 25,902 | 25,907 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $38,913 | $26,004 | $110,777 | $85,077 |
Gross Profit | 38,913 | 26,004 | 108,740 | 85,077 |
EBITDA | -75,986 | -235,034 | 39,838 | -5,158 |
EBIT | -77,137 | -235,877 | 37,801 | -6,877 |
Net Income | -77,424 | -219,710 | 35,379 | -25,687 |
Net Change In Cash | 38,913 | 26,004 | 110,777 | 85,077 |
Cost of Revenue | -7,418 | -24,628 | ||
Free Cash Flow | -32,767 | -51,367 | -32,832 | -61,467 |
Cash | 212,610 | 76,911 | 106,438 | 114,057 |
Basic Shares | 23,689 | 5,170 | 4,052 | 3,175 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.73 |
2025-06-30 | -$0.77 |
2025-03-31 | -$0.65 |
2024-12-31 | -$0.59 |
